|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 05795012.3 (espacenet) (Federated) (European Patent Register), 20050909 | | Patent/reg. no. and date | DK/EP 1789084, 20101117 | | Publication date | 20070530 | | Priority no. and date | EP 04255471, 20040909 | | EP pub. no. and date |
EP 1789084 20070530 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
CH-4056 Basel, CH | | Applicant ref. no. | P47960DK01 | | Inventor | GREGERSEN, Jens-Peter,
Chiron Behring GmbH & Co., Emil-von-Behring-Str. 76
35041 Marburg, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/145 (2006.01) , C12Q 1/70 (2006.01) | | Title | Nedsættelse af potentiellle iatrogene risici forbundet med influenzavacciner | | Int. application no. | IB2005003266 | | Int. publication no. | WO2006027698 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
